Getinge Acquires Paragonix Technologies
August 22, 2024
Getinge has completed the acquisition of Paragonix Technologies, a U.S. developer of organ preservation devices and transplant logistics services, for an estimated total consideration of USD 477 million (including earn-outs). The deal will make Paragonix a wholly owned subsidiary of Getinge and is intended to expand Getinge's transplant product portfolio and bring Paragonix's technologies to new global markets.
- Buyers
- Getinge
- Targets
- Paragonix Technologies
- Sellers
- Signet Healthcare Partners
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
AMETEK Acquires Paragon Medical from American Securities for ~$1.9B
October 31, 2023
Medical Devices
AMETEK, Inc. has agreed to acquire Paragon Medical, a Pierceton, Indiana-based contract manufacturer of medical components and instruments, from private equity firm American Securities in an all-cash transaction valued at approximately $1.9 billion. The deal advances AMETEK’s capabilities and footprint in medical device manufacturing and is subject to customary closing conditions and regulatory approvals.
-
Getinge Acquires Verrix
November 12, 2021
Medical Devices
Getinge has acquired Verrix LLC, a San Clemente, California-based medical device company developing sterility assurance and infection-control technologies. Outcome Capital served as exclusive strategic and financial advisor to Verrix; Getinge said the acquisition secures its entry into the hospital sterility monitoring segment and expands its infection-control product offering.
-
Elevance Health Acquires Paragon Healthcare
March 11, 2024
Healthcare Services
Elevance Health has closed its acquisition of Plano, Texas–based Paragon Healthcare, an infusion services and drug therapy provider operating more than 40 ambulatory infusion centers and serving over 35,000 patients. Paragon will operate under Elevance’s CarelonRx pharmacy services segment to expand access to specialty medications and scale infusion capabilities; financial terms were not disclosed (Axios reported the purchase may exceed $1 billion).
-
Paragon 28 Acquires Assets of Additive Orthopaedics
June 1, 2021
Medical Devices
Paragon 28, Inc. acquired the product lines and related assets of Additive Orthopaedics, including the FDA‑cleared 3D‑printed patient‑specific talus spacer and an integrated cloud‑based pre‑operative surgical planning application. The acquisition expands Paragon 28’s foot‑and‑ankle product offering and accelerates its strategy to integrate smart tools, AI and advanced technologies to improve patient outcomes.
-
Peak Rock Capital Affiliate Acquires Paragon Healthcare, Inc.
September 15, 2020
Healthcare Services
An affiliate of Peak Rock Capital completed the acquisition of Paragon Healthcare, Inc., a provider of ambulatory and home infusion services and specialty pharmacy. Peak Rock said it will partner with Paragon's management to support geographic expansion and continued growth through organic initiatives and strategic acquisitions.
-
TTI's Exponential Technology Group Acquires Paragon Innovations
September 13, 2021
Engineering Services
Exponential Technology Group (XTG) at TTI, Inc., a Berkshire Hathaway company, has acquired Paragon Innovations, an engineering design services firm based in Richardson, Texas. Paragon will continue to operate under its brand with founder Michael Wilkinson remaining as Vice President and General Manager; the deal expands TTI/XTG's product design and engineering services capabilities and complements its earlier acquisition, Connected Development.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.